Early cardiac response (90 days) in stage IIIb AL amyloidosis. Survival in patients with a cardiac response (median survival, 54 months), cardiac stable disease (median survival, 20 months), or cardiac progression (median survival, 6 months). (A) Survival according to depth of cardiac response: cardiac VGPR (median survival, 92 months), cardiac PR (median survival, 24 months), and cardiac NR (median survival, 6 months). (B) Survival according cardiac response in patients who attained a profound hematologic response (ie, at least VGPR). (C) Ninety-day landmark analysis was performed.